N O Davidson

Author PubWeight™ 89.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999 6.67
2 Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 1993 3.52
3 Troglitazone action is independent of adipose tissue. J Clin Invest 1997 2.50
4 A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med 1998 2.43
5 Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 1992 2.35
6 The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem 1993 1.93
7 Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J Biol Chem 1995 1.66
8 Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 1996 1.56
9 apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem 1995 1.39
10 Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5. Am J Physiol 1993 1.38
11 Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J Invest Dermatol 1999 1.37
12 Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem 2001 1.32
13 Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing. J Biol Chem 2000 1.24
14 Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest 1990 1.24
15 Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J Biol Chem 1994 1.23
16 An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability. Mol Cell Biol 2000 1.20
17 Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein. Nucleic Acids Res 1994 1.20
18 Evolution of intestinal apolipoprotein B mRNA editing. Chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s). J Biol Chem 1992 1.17
19 Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am J Physiol 1987 1.12
20 Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity. J Biol Chem 2001 1.11
21 Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing. J Lipid Res 1995 1.09
22 Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J Biol Chem 1990 1.07
23 Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J Clin Invest 1991 1.04
24 Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. Biochim Biophys Acta 2001 1.01
25 Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am J Physiol 1996 0.99
26 Variations in dietary triacylglycerol saturation alter the lipid composition and fluidity of rat intestinal plasma membranes. Biochim Biophys Acta 1985 0.98
27 Molecular mechanisms of apolipoprotein B mRNA editing. Curr Opin Lipidol 2001 0.97
28 ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. Am J Physiol Cell Physiol 2001 0.96
29 Dextran sodium sulfate inhibition of real-time polymerase chain reaction amplification: a poly-A purification solution. Inflamm Bowel Dis 2011 0.95
30 Apolipoprotein B mRNA abundance is decreased by eicosapentaenoic acid in CaCo-2 cells. Effect on the synthesis and secretion of apolipoprotein B. Arterioscler Thromb 1992 0.95
31 Apolipoprotein B synthesis in rat small intestine: regulation by dietary triglyceride and biliary lipid. J Lipid Res 1986 0.94
32 REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. J Lipid Res 1994 0.93
33 Homeodomain factor Nkx2-3 controls regional expression of leukocyte homing coreceptor MAdCAM-1 in specialized endothelial cells of the viscera. Dev Biol 2000 0.93
34 Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc Natl Acad Sci U S A 1994 0.91
35 K-ras mutations in 1,2-dimethylhydrazine-induced colonic tumors: effects of supplemental dietary calcium and vitamin D deficiency. Cancer Res 1991 0.91
36 In vitro cholesterol synthesis in freshly isolated mononuclear cells of human blood: effect of in vivo administration of clofibrate and/or cholestyramine. J Lipid Res 1980 0.90
37 Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues. J Biol Chem 1990 0.89
38 Apolipoprotein A-I synthesis in rat small intestine: regulation by dietary triglyceride and biliary lipid. J Lipid Res 1985 0.89
39 GLUT3 glucose transporter isoform in rat testis: localization, effect of diabetes mellitus, and comparison to human testis. Am J Physiol 1994 0.88
40 Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem J 1991 0.88
41 Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. J Thromb Haemost 2005 0.87
42 Intestinal apolipoprotein A-I and B-48 metabolism: effects of sustained alterations in dietary triglyceride and mucosal cholesterol flux. J Lipid Res 1987 0.87
43 Intestinal and hepatic apolipoprotein B gene expression in abetalipoproteinemia. Gastroenterology 1991 0.87
44 Characterization of the human apobec-1 gene: expression in gastrointestinal tissues determined by alternative splicing with production of a novel truncated peptide. J Lipid Res 1997 0.86
45 Effect of polyamine oxidase inhibition on the colonic malignant transformation process induced by 1,2-dimethylhydrazine. Carcinogenesis 1990 0.86
46 Hospital and geographic variability in two colorectal cancer surgery outcomes: complications and mortality after complications. Ann Surg Oncol 2014 0.85
47 An alternatively spliced form of apobec-1 messenger RNA is overexpressed in human colon cancer. Gastroenterology 1998 0.85
48 Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes. Metabolism 1998 0.85
49 Developmental regulation of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (APOBEC-1) in human small intestine. J Lipid Res 1995 0.84
50 Cloning and characterization of the rat apobec-1 gene: a comparative analysis of gene structure and promoter usage in rat and mouse. J Lipid Res 1997 0.84
51 Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res 1998 0.84
52 Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells. Endocrinology 1994 0.84
53 Proposed nomenclature for the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme: APOBEC-1. RNA 1995 0.83
54 Postoperative 30-day mortality in patients undergoing surgery for colorectal cancer: development of a prognostic model using administrative claims data. Cancer Causes Control 2014 0.83
55 Regulation of sterol carrier protein-2 gene expression in rat liver and small intestine. J Lipid Res 1993 0.83
56 Cholesterol absorption in man: effect of administration of clofibrate and/or cholestyramine. J Lipid Res 1980 0.82
57 An improved reverse transcription-polymerase chain reaction method to study apolipoprotein gene expression in Caco-2 cells. J Lipid Res 1994 0.82
58 Disruption of hedgehog signalling in ApoE - /- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophages. J Pathol 2007 0.82
59 Intestinal apolipoprotein A-IV gene expression in the piglet. J Lipid Res 1990 0.81
60 Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther 1996 0.81
61 Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a). J Biol Chem 1997 0.81
62 Escherichia coli sepsis increases hepatic apolipoprotein B secretion by inhibiting degradation. Lipids 2000 0.81
63 Unreliability of tritiated cholesterol: studies with [1,2-3H]-cholesterol and [24,25-3H]cholesterol in humans. Proc Natl Acad Sci U S A 1980 0.80
64 TPA causes divergent responses of Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC in the nuclei of Caco-2 cells. Biochim Biophys Acta 1994 0.79
65 Apolipoprotein B messenger RNA editing is developmentally regulated in pig small intestine: nucleotide comparison of apolipoprotein B editing regions in five species. Biochem Biophys Res Commun 1990 0.79
66 Apolipoprotein(a) synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion. J Biol Chem 1998 0.79
67 Intestinal apolipoprotein synthesis and secretion in the suckling pig. J Lipid Res 1989 0.79
68 Assignment of the gene encoding the human apolipoprotein B mRNA editing enzyme (APOBEC1) to chromosome 12p13.1. Genomics 1994 0.79
69 The binding of apobec-1 to mammalian apo B RNA is stabilized by the presence of complementation factors which are required for post-transcriptional editing. Nucleic Acids Symp Ser 1995 0.78
70 Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizes. Proc Natl Acad Sci U S A 1983 0.78
71 Apolipoprotein B messenger RNA editing in rat liver: developmental and hormonal modulation is divergent from apolipoprotein A-IV gene expression despite increased hepatic lipogenesis. J Lipid Res 1992 0.78
72 Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase. Biol Chem 1998 0.78
73 Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. J Lipid Res 1998 0.77
74 A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity. Mol Biochem Parasitol 1997 0.77
75 Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochim Biophys Acta 1995 0.76
76 Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes. Chem Phys Lipids 1994 0.76
77 Sequence elements required for apolipoprotein B mRNA editing enhancement activity from chicken enterocytes. Biochem Biophys Res Commun 1999 0.76
78 Apolipoprotein E polymorphism: another player in the genetics of colon cancer susceptibility? Gastroenterology 1996 0.76
79 Apolipoprotein B mRNA editing is preserved in the intestine and liver of zinc-deficient rats. J Nutr 1996 0.76
80 Education and Imaging. Gastrointestinal: schistosomiasis-diagnosis by colonoscopy. J Gastroenterol Hepatol 2013 0.75
81 Phospholipid flippase, low HDL levels, and intestinal fat absorption: a new look at the ABCs of enterohepatic lipid flux. Gastroenterology 2000 0.75
82 Intestinal Apo B48 secretion: a novel surrogate marker of pancreatic exocrine function. Am J Gastroenterol 1999 0.75
83 Measurement of bile acid production in hyperlipidemic man: does phenotype or methodology make the difference? J Lipid Res 1981 0.75
84 Bile acid production in human subjects: rate of oxidation of [24,25-3H]cholesterol compared to fecal bile acid excretion. J Lipid Res 1986 0.75
85 Increased hepatic synthesis and accumulation of plasma apolipoprotein B100 in copper-deficient rats does not result from modification in apolipoprotein B mRNA editing. Lipids 1996 0.75